MARKET TALK: BarCap Upgrades GlaxoSmithKline To Overweight

11th Jun 2010 07:33

0633 GMT [Dow Jones] Barclays Capital upgrades GlaxoSmithKline (GSK) to overweight from equalweight, and keeps its price target at 1380p. Says investor concerns around Avandia and Advair are overdone. Adds the stock seems cheap with a dividend yield of 6.2%, a free cashflow yield of 12%, and 17% upside to BarCap's DCF valuation. Says in this climate boring is beautiful. Shares closed at 1164p. ([email protected]) Contact us in London. +44-20-7842-9464 [email protected] (END) Dow Jones Newswires June 11, 2010 02:33 ET (06:33 GMT)

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.